20251218 170304 In a move with potential implications for the global ganja industry, including Jamaica's growing medicinal ganja sector, United States President Donald Trump has signed an executive order to fast-track the reclassification of ganja under US federal law. The order directs that ganja be moved from its current classification, alongside hard drugs such as heroin and LSD, to a Schedule III substance. That category includes drugs considered to have a moderate to low risk of dependence, such as Tylenol with codeine, ketamine, and testosterone. President Trump says the aim is to expand research into medical ganja and CBD, allowing the U.S. Food and Drug Administration to more fully study its medicinal benefits and risks. This reclassification order will make it far easier to conduct marijuana-related medical
